パーキンソン病:グローバル医薬品市場予測及び分析(~2022)...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 16
1.2 List of Figures 22
2 Introduction 23
2.1 Catalyst 23
2.2 Related Reports 23
3 Disease Overview 24
3.1 Etiology and Pathophysiology 24
3.1.1 Etiology 24
3.1.2 Pathophysiology 27
3.1.3 Prognosis 29
3.1.4 Quality of Life 30
3.2 Symptoms 30
4 Epidemiology 32
4.1 Disease Background 32
4.2 Risk Factors and Comorbidities 32
4.2.1 The risk of developing Parkinson’s disease progressively increases with age 33
4.2.2 The risk for Parkinson’s disease is increased with Parkinson’s disease-causing mutations 34
4.2.3 Men are 1.5 times more likely to develop Parkinson’s disease than women, though the difference may be the result of varying exposures to environmental factors 34
4.2.4 Chemicals, along with exposure to other environmental factors, increase the risk of developing Parkinson’s disease 35
4.2.5 38% of Parkinson’s disease cases experienced depression and/or anxiety compared with only 8% of controls 35
4.3 Global and Historical Trends 36
4.3.1 US 36
4.3.2 5EU 37
4.3.3 Japan 37
4.3.4 Brazil 38
4.4 Forecast Methodology 39
4.4.1 Sources Used 40
4.4.2 Sources Not Used 43
4.4.3 Forecast Assumptions and Methods 43
4.5 Epidemiological Forecast of Parkinson’s Disease (2012-2022) 44
4.5.1 Prevalent Cases of Parkinson’s Disease 44
4.5.2 Age-Specific Prevalent Cases of Parkinson’s Disease 46
4.5.3 Sex-Specific Prevalent Cases of Parkinson’s Disease 48
4.5.4 Age-Standardized Prevalence of Parkinson’s Disease 49
4.6 Discussion 50
4.6.1 Epidemiological Forecast Insight 50
4.6.2 Limitations of the Analysis 51
4.6.3 Strengths of the Analysis 52
5 Disease Management 53
5.1 Overview 53
5.1.1 Diagnosis – The UK Brain Bank Criteria 53
5.1.2 Treatment Guidelines and Leading Prescribed Drugs 54
5.2 Treatment Synopsis 57
5.2.1 Dopaminergic Therapy Classes 57
5.2.2 Treatment of Parkinson’s Disease by Stage 59
5.2.3 Other Treatment Options 62
5.3 Parkinson’s Disease Assessment Scales 62
5.3.1 Unified Parkinson’s Disease Rating Scale (UPDRS) 63
5.3.2 Hoehn and Yahr Clinical Staging 65
5.3.3 Other Clinical Assessments 66
5.4 Diagnosis and Treatment of Parkinson’s Disease by Country 66
5.4.1 US 66
5.4.2 France 68
5.4.3 Germany 70
5.4.4 Italy 72
5.4.5 Spain 75
5.4.6 UK 77
5.4.7 Japan 78
5.4.8 Brazil 81
6 Competitive Assessment 84
6.1 Overview 84
6.2 Strategic Competitor Assessment 86
6.3 Product Profiles – Levodopa Combination Therapy 87
6.3.1 Madopar (levodopa/benserazide) 88
6.3.2 Sinemet (carbidopa/levodopa) 93
6.3.3 Duodopa (carbidopa/levodopa intestinal gel) 99
6.4 Product Profiles – COMT Inhibitors 103
6.4.1 Stalevo/Comtan (entacapone) 103
6.5 Dopamine Agonists 109
6.5.1 Neupro (rotigotine transdermal patch) 110
6.5.2 Requip/Requip XL (ropinirole) 117
6.5.3 Apokyn (apomorphine) 121
6.6 Product Profiles – MAO-B Inhibitors 126
6.6.1 Azilect (rasagiline) 127
6.7 Product Profiles – Adenosine 2A Inhibitor 133
6.7.1 Nouriast (istradefylline) 134
6.8 Product Profiles – Other Therapies 137
7 Opportunity and Unmet Need 139
7.1 Overview 139
7.2 Treatment of Motor Complications – Dyskinesias and OFF Episodes 141
7.2.1 Unmet Need 141
7.2.2 Gap Analysis 143
7.2.3 Opportunity 146
7.3 Treatment of Non-Motor Symptoms and Dementia 146
7.3.1 Unmet Need 146
7.3.2 Gap Analysis 147
7.3.3 Opportunity 149
7.4 Neuroprotective/Disease-Modifying Agents 149
7.4.1 Unmet Need 149
7.4.2 Gap Analysis 150
7.4.3 Opportunity 153
7.5 Improved Drug Formulations 154
7.5.1 Unmet Need 154
7.5.2 Gap Analysis 154
7.5.3 Opportunity 155
7.6 Identification of Reliable Biomarkers 155
7.6.1 Unmet Need 155
7.6.2 Gap Analysis 156
7.6.3 Opportunity 157
7.7 Improved Clinical Trial Design 157
7.7.1 Unmet Need 157
7.7.2 Gap Analysis 158
7.7.3 Opportunity 158
8 Pipeline Assessment 159
8.1 Overview 159
8.2 Clinical Trial Mapping 159
8.2.1 Clinical Trials by Class/Patient Population/Biomarkers/Line of Therapy 159
8.3 Promising Drugs in Clinical Development 161
8.3.1 Safinamide 163
8.3.2 Tozadenant 171
8.3.3 CVT-301 175
8.3.4 Rytary/IPX066 181
8.3.5 Opicapone 188
8.3.6 Mavoglurant/AFQ056 193
8.3.7 CD/LD-GR 196
8.3.8 Other Late-Stage Pipeline Products 201
9 Current and Future Players 202
9.1 Overview 202
9.2 Trends in Corporate Strategy 203
9.3 Company Profiles 204
9.3.1 Merck 204
9.3.2 Roche 206
9.3.3 AbbVie 208
9.3.4 UCB 210
9.3.5 GlaxoSmithKline 211
9.3.6 Novartis 213
9.3.7 Orion 216
9.3.8 Newron 217
9.3.9 Civitas 219
9.3.10 Impax 221
9.3.11 Lundbeck 223
10 Market Outlook 226
10.1 Global Markets 226
10.1.1 Forecast 226
10.1.2 Drivers and Barriers – Global Issues 230
10.2 US 232
10.2.1 Forecast 232
10.2.2 Key Events 237
10.2.3 Drivers and Barriers 237
10.3 France 239
10.3.1 Forecast 239
10.3.2 Key Events 243
10.3.3 Drivers and Barriers 243
10.4 Germany 245
10.4.1 Forecast 245
10.4.2 Key Events 249
10.4.3 Drivers and Barriers 249
10.5 Italy 251
10.5.1 Forecast 251
10.5.2 Key Events 255
10.5.3 Drivers and Barriers 255
10.6 Spain 257
10.6.1 Forecast 257
10.6.2 Key Events 262
10.6.3 Drivers and Barriers 262
10.7 UK 264
10.7.1 Forecast 264
10.7.2 Key Events 268
10.7.3 Drivers and Barriers 268
10.8 Japan 270
10.8.1 Forecast 270
10.8.2 Key Events 274
10.8.3 Drivers and Barriers 274
10.9 Brazil 276
10.9.1 Forecast 276
10.9.2 Key Events 280
10.9.3 Drivers and Barriers 280
11 Appendix 282
11.1 Bibliography 282
11.2 Abbreviations 300
11.3 Methodology 305
11.4 Forecasting Methodology 305
11.4.1 Diagnosed Parkinson’s Disease Patients 305
11.4.2 Percent Drug-Treated Patients 306
11.4.3 Drugs Included in Each Therapeutic Class 306
11.4.4 Launch and Patent Expiry Dates 307
11.4.5 General Pricing Assumptions 308
11.4.6 Compliance Assumptions 309
11.4.7 Individual Drug Assumptions 310
11.4.8 Generic Erosion 320
11.4.9 Pricing of Pipeline Agents 320
11.5 Physicians and Specialists Included in this Study 321
11.6 About the Authors 323
11.6.1 Author 323
11.6.2 Epidemiologist 324
11.6.3 Global Head of Healthcare 325
11.7 About GlobalData 326
11.8 Disclaimer 326


【レポート販売概要】

■ タイトル:パーキンソン病:グローバル医薬品市場予測及び分析(~2022)
■ 英文:PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022
■ 発行日:2014年3月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC82PIDR
■ 調査対象地域:グローバル
  • 自動車用電子制御ユニット(ECU)の世界市場2017-2021
    About Automotive ECU ECU is a computer that controls one or many electrical systems in a vehicle. Modern ECUs employ both microprocessors and microcontrollers depending on the computational requirements. The operation of an ECU is similar to that of the basic input/output system (BIOS) of a computer. Technavio’s analysts forecast the global automotive ECU market to grow at a CAGR of 7.4% during th …
  • 酢酸エチル(ETAC)の世界市場動向及び予測2015
    The present report is an essential resource for a one looking for detailed information on the world ethyl acetate market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true ins …
  • 世界の近接センサー市場2015
    The Global Proximity Sensors Industry Report 2015 is a professional and in-depth study on the current state of the Proximity Sensors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Proximity Sensors market analysis is provided for the international markets including development trends, competitive …
  • BRIC(ブラジル/ロシア/インド/中国)の建設支出市場2016-2020
    About Construction Spending in BRIC Countries The construction market in BRIC countries is booming, as these nations' governments are making efforts to improve the overall infrastructure, which is leading to increased investments in construction during the forecast period. Multiple initiatives are being announced by governments across BRIC countries to focus on the development of infrastructure su …
  • 米国のフレキシブルパッケージング(軟包装)市場予測
    The U.S. flexible packaging market has been growing in accordance with the growth in the packaging industry. It isreplacing traditional packaging types such as metal cans. Factors such as growth in consumer preferences for convenient packaging, increase in demand from food & healthcare sector, ease of use, and light weight is driving the demand for flexible packaging in the U.S. The segmentation c …
  • 二輪車向けサイドビューアシストシステム(MSVAS)の世界市場2016-2020
    About MSVAS MSVAS is an early warning system for a motorcycle rider, which constantly monitors the rider's blind spots and helps in lane changing decisions. The current MSVAS consists of a sensor array, with a sensor placed at each strategic location at the front and rear ends of the motorcycle. While the rear sensors are used for monitoring the blind spots in the current and surrounding lanes as …
  • 特殊スピリッツ(蒸留酒)の世界市場2016-2020
    About Specialty Spirits Specialty spirits are region-specific traditional spirits. Baijiu in China, soju in South Korea, sochu in Japan, Cachaça in Brazil, and raki in Turkey are some of the popular specialty spirits. The global specialty spirits market is dominated by APAC. China is the largest market for specialty spirits. Rising disposable incomes, especially in developing nations, coupled with …
  • 世界のモバイル健康/フィットネス機器用センサー市場
    About Mobile Health and Fitness Sensors A sensor measures physical quantity and converts raw data into observable data, which are used by various industries. Mobile health and fitness sensors are used in health and fitness devices to measure various body parameters. Rapid and continuous development in sensing technology can assist in regular patient monitoring. This would help in bringing down hea …
  • 自動車用サスペンションコイルスプリングの世界市場2019-2023
    About this market Automobiles are becoming intelligent and smarter in terms of functionality and capabilities. This is because modern vehicles are finding greater application of electronics at the systems and components levels during the designing and manufacturing processes. Automotive components and parts made using materials such as steel, aluminum and others are helping improve performance, re …
  • 世界の乳製品市場:ミルク、チーズ、ヨーグルト、バター等
    About Dairy Food Dairy food refers to food products produced from milk sourced primarily from cows, goats, sheep, yaks, horses, camels, and buffaloes. They are usually considered as high energy-yielding food products. The Global Dairy Food market includes various products like milk, cheese, yogurt, butter, cream, curd, and milk powder. The Global Dairy Food market has witnessed the emergence of ne …
  • 遊園地の世界市場2017-2021
    About Amusement Parks Amusement parks attract and entertain individuals through a variety of adventure games such as water and dry rides. Amusement parks charge customers a pre-defined fee for delivering these services. They contribute immensely to the world GDP and employment. Amusement parks generate revenue through many streams such as tickets, hospitality, merchandizing, licensing, and events. …
  • Rosetta Resources Inc.社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)
    Rosetta Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Rosetta Resources Inc. (Rosetta Resources) is an independent oil and gas company. It acquires, explores and develops onshore energy resources in the US. The company engages in the production of oil, natural gas and natural gas liquids (NGLs). The core operating areas of the company are the E …
  • トランザクション監視ソフトウェアの世界市場:コンポーネント別(ソリューション、サービス)、展開モデル別(オンプレミス、クラウド)、組織規模別(大企業、中小企業)、用途別(マネーロンダリング防止、顧客ID管理、不正の検出と防止、コンプライアンス管理)、業種別(Bfsi、政府と防衛、小売、IT/テレコム、ヘルスケア)
    Transaction monitoring is the process of administering, reviewing, and analyzing the transaction processed on an information system or on a business application. The main function of transaction monitoring is to monitor the customer transactions, which include assessing customers’ historical as well as current information and interactions to provide a complete picture of the customer activity. Thi …
  • データストレージ用途向け固体レーザーの世界市場
    About Solid-state Lasers A laser (light amplification by stimulated emission of radiation) is a device that produces a concentrated beam of coherent monochromatic electromagnetic radiation by stimulated emission of photons from excited molecules. These devices are widely used in applications such as communications, material processing, excimer lithography, data storage, medical and aesthetic, scie …
  • Arcan Resources Ltd.:石油・ガスの開発・生産動向及びコスト分析– Q4, 2012
    Arcan Resources Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Arcan Resources Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。